ReShape Lifesciences (NASDAQ:RSLS) Shares Scheduled to Reverse Split on Monday, September 23rd

ReShape Lifesciences Inc. (NASDAQ:RSLS)’s stock is scheduled to reverse split on Monday, September 23rd. The 1-58 reverse split was announced on Thursday, September 19th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, September 20th.

ReShape Lifesciences Price Performance

NASDAQ RSLS opened at $0.11 on Friday. The business has a fifty day moving average price of $0.18 and a 200 day moving average price of $0.18. ReShape Lifesciences has a one year low of $0.11 and a one year high of $0.67.

ReShape Lifesciences (NASDAQ:RSLS) last released its earnings results on Wednesday, August 14th. The medical device company reported ($0.06) earnings per share (EPS) for the quarter. The business had revenue of $1.97 million for the quarter. ReShape Lifesciences had a negative return on equity of 208.37% and a negative net margin of 112.11%.

Analyst Ratings Changes

Separately, Maxim Group reiterated a “hold” rating on shares of ReShape Lifesciences in a report on Wednesday, July 17th.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.